Second Primary Cancer Risk Shifts Over Time

• by Andrea Surnit

• May 5, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

Risk models may improve lung cancer screening

Analysis found no single prediction model optimized screening eligibility, sensitivity, and efficiency across all racial and ethnic groups.

• by Olivia Anderson

• August 24, 2026

• 3 min

Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis

• by Dandan Liang, Qinghua Liu, Min Liu, Yi Li

• September 1, 2026